Last reviewed · How we verify
NCT05751109
Comparison of IPACK and Adductor Canal Block Combination Versus Epidural Analgesia for Total Knee Arthroplasty
trial testing ipack+adduktor kanal in Knee Injuries in 80 participants. Completed in 1 October 2023.
16 August 2023
Quick facts
| Lead sponsor | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 August 2022 |
| Primary completion | 16 August 2023 |
| Estimated completion | 1 October 2023 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- ipack+adduktor kanal
Conditions studied
- Knee Injuries — all drugs for Knee Injuries →
Sponsor
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Who can join
Adults 18 to 65, any sex, with Knee Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the efficacy and complications of IPACK and adductor canal block combination and epidural block in patients who will be operated for knee arthroscopy under spinal anesthesia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05751109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Injuries
Currently open trials in the same condition.
- NCT07300098 — Epidemiological Evaluation of Knee Injuries in Children Admitted to Assiut University Hospitals From 2022 to 2025. · active not recruiting
- NCT07201597 — Correlation Between Psychological Readiness, Knee Function, and Isokinetic Performance After Anterior Cruciate Ligament · recruiting
- NCT06541756 — Fibrine Clot-augmented Repair of Longitudinal Meniscus Tears · NA · recruiting
- NCT06442319 — The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction. · NA · recruiting
- NCT06195423 — Stopping OsteoARthritis After an ACL Tear · NA · recruiting
Other Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization trials
Trials by the same sponsor.
- NCT07500285 — Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Ph · Phase 2 · not yet recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07390279 — Efficacy of Transcutaneous Pulsed Radiofrequency in Postherpetic Neuralgia · recruiting
- NCT07357922 — Serum Progesterone and Threatened Abortion During Lactation · not yet recruiting
- NCT07283250 — Development and Validation of the Air Quality Awareness Scale (AQAS) for Parents · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05751109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05751109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing